Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Core Laboratories (MEX:CLB) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Core Laboratories Forward PE Ratio Related Terms
Core Laboratories Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Core Laboratories's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Laboratories Forward PE Ratio Chart
Core Laboratories Annual Data
Trend
2024-12
2025-12
Forward PE Ratio
43.97
56.88
Core Laboratories Quarterly Data
2019-09
2020-03
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
18.42
22.62
43.97
48.84
59.27
59.27
56.88
62.45
MEX:CLB vs EROK, OIS, NGS: Forward PE Ratio Comparison
For the Oil & Gas Equipment & Services subindustry, Core Laboratories's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Core Laboratories Forward PE Ratio vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, Core Laboratories's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Core Laboratories's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Core Laboratories (MEX:CLB) has a Forward PE Ratio of 77.61 as of Jul. 15, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Core Laboratories and its competitors. According to the industry distribution chart, Core Laboratories ranks #443 out of 543 companies in the Oil & Gas industry, placing it in the top 81.6%.
Is Core Laboratories' Forward PE Ratio too high?
Core Laboratories' current Forward PE Ratio is 77.61. The Oil & Gas industry median Forward PE Ratio is 10.97. Core Laboratories' value of 77.61 is 607.5% above this industry median. Based on the distribution chart, Core Laboratories ranks #443 out of 543 companies in the Oil & Gas industry, which is in the bottom quartile relative to peers. Overall, Core Laboratories has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' Forward PE Ratio compare to EROK and OIS?
According to the Oil & Gas industry distribution chart, Core Laboratories ranks #443 out of 543 companies for Forward PE Ratio. This places Core Laboratories in the lower half of its industry. The industry median Forward PE Ratio is 10.97. Core Laboratories' value of 77.61 is 607.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for an Oil & Gas company?
The median Forward PE Ratio among Oil & Gas companies is 10.97, based on 543 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Core Laboratories's current Forward PE Ratio of 77.61 is 607.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Core Laboratories and its competitors. For the Oil & Gas industry, the median Forward PE Ratio is 10.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Core Laboratories's current Forward PE Ratio is 77.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Core Laboratories (MEX:CLB) has a current Forward PE Ratio of 77.61. The stock's GF Value™ is MXN1,333.14, compared to a current price of MXN856.38 — trading 35.8% below its estimated fair value. The current Forward PE Ratio is 77.61 and 607.5% above the Oil & Gas industry median of 10.97. Core Laboratories' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Core Laboratories (MEX:CLB), the current Forward PE Ratio is 77.61 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Core Laboratories (MEX:CLB) Overvalued in 2026?
Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued.
The current stock price of MXN856.38 is trading 35.8% below its estimated GF Value™ of MXN1,333.14.
Key valuation signals for MEX:CLB:
Forward PE Ratio: 77.61
GF Value™: MXN1,333.14 vs. price of MXN856.38 (35.8% below fair value)
Industry Position: 607.5% above the Oil & Gas median (#443 of 543)
No single metric tells the full story. See the MEX:CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
62GF Score
Get the complete analysis for MEX:CLB
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CLB has been successfully added to your 
